Amedeo Smart

Free Medical Literature Service

 

Amedeo

Arrhythmias
  Free Subscription

Articles published in
Eur Heart J
    February 2026
  1. SELLAL JM, Dib N, Karakachoff M, McLeod CJ, et al
    Arrhythmias in congenitally corrected transposition of the great arteries: an international study.
    Eur Heart J. 2026;47:831-838.
    >> Share

  2. WALDMANN V, Duthoit G, Pasquie JL, Champ-Rigot L, et al
    Catheter ablation in congenital heart diseases: a French nationwide study.
    Eur Heart J. 2026;47:816-827.
    >> Share

  3. GALLI M, Patrono C
    Weekly Journal Scan: Long-term antithrombotic therapy for patients with atrial fibrillation and drug-eluting stents: primum non nocere.
    Eur Heart J. 2026 Feb 18:ehag062. doi: 10.1093.
    >> Share

  4. ROSSI FB, Sammarco A, Seccia TM
    Potassium and aldosterone as determinants of new-onset atrial fibrillation.
    Eur Heart J. 2026 Feb 13:ehag057. doi: 10.1093.
    >> Share

  5. HESSELLUND AK, Svendsen JH, Diederichsen SZ
    Hypokalaemia and atrial fibrillation: a data-driven perspective.
    Eur Heart J. 2026 Feb 13:ehag058. doi: 10.1093.
    >> Share

  6. CREA F
    Focus on trials: atrial fibrillation, heart failure with reduced ejection fraction, acute coronary syndrome, ischaemic stroke, and renovascular hypertension.
    Eur Heart J. 2026;47:649-654.
    >> Share

  7. CAI L, Wan H, Sun Y, Middeldorp ME, et al
    Atrial fibrillation: an underappreciated complication of diabetes.
    Eur Heart J. 2026 Feb 11:ehag044. doi: 10.1093.
    >> Share

  8. SEPEHRI SHAMLOO A, Dagres N
    Subcutaneous implantable cardioverter-defibrillators enter maturity: HONEST lessons from a nationwide cohort.
    Eur Heart J. 2026 Feb 9:ehaf1094. doi: 10.1093/eurheartj/ehaf1094.
    >> Share

  9. MIGLIORE F, Ottaviano L, Priori SG
    Programming optimization is crucial for minimizing inappropriate shocks in patients with Brugada syndrome with a subcutaneous implantable cardioverter-defibrillator.
    Eur Heart J. 2026 Feb 6:ehag007. doi: 10.1093.
    >> Share

  10. BERGONTI M, Conte G
    Sex differences in atrial fibrillation-related atrial remodelling: the end of the debate?
    Eur Heart J. 2026 Feb 4:ehag045. doi: 10.1093.
    >> Share

    January 2026
  11. RAVEENDRA K, Nadarajah R, Larvin H, Farooq M, et al
    Non-antiarrhythmic pharmacotherapy in cardio-renal-metabolic disease and incident atrial fibrillation: a trial meta-analysis.
    Eur Heart J. 2026 Jan 28:ehag021. doi: 10.1093.
    >> Share

  12. JAIS P, Neuzil P, Scherr D, Frison E, et al
    Pulsed field vs radiofrequency ablation for paroxysmal atrial fibrillation: the BEAT PAROX-AF trial.
    Eur Heart J. 2026 Jan 22:ehaf1115. doi: 10.1093/eurheartj/ehaf1115.
    >> Share

  13. MYRSTAD M
    A broken heart: 100 years since the first diagnosis of atrial fibrillation in an athlete.
    Eur Heart J. 2026 Jan 12:ehaf859. doi: 10.1093.
    >> Share

  14. LOWRES N, Orchard JJ, Freedman B
    Digital heartbeat: wearables for early detection and integrated management of atrial fibrillation.
    Eur Heart J. 2026 Jan 8:ehaf998. doi: 10.1093.
    >> Share

  15. XIE D, Liang D, Zhou L, Liu Y, et al
    Cardiac endogenous transmitter system: molecular features, functions, and clinical implications.
    Eur Heart J. 2026;47:188-198.
    >> Share

  16. FINOCCHIARO G, Zorzi A, Abela M, Baggish A, et al
    Abnormal electrocardiogram findings in athletes.
    Eur Heart J. 2026;47:152-169.
    >> Share

  17. CREA F
    Focus on arrhythmias: cardiac endogenous transmitter systems, atrial fibrillation, and short QT and Brugada syndromes.
    Eur Heart J. 2026;47:139-144.
    >> Share

  18. PERETTO G, Merlo M, Ambrosi A, Bacigalupi E, et al
    Major arrhythmias in non-dilated left ventricular cardiomyopathy: a novel prediction score.
    Eur Heart J. 2026;47:94-106.
    >> Share

    December 2025
  19. JOHNSON R, Fletcher RA, Peters S, Ohanian M, et al
    Titin-related familial dilated cardiomyopathy: factors associated with disease onset.
    Eur Heart J. 2025;46:5240-5257.
    >> Share

  20. KERKOURI F, Marquie C, Boveda S, Anselme F, et al
    Long-term outcomes of subcutaneous implantable cardioverter defibrillators: the French nationwide HONEST study.
    Eur Heart J. 2025 Dec 19:ehaf918. doi: 10.1093.
    >> Share

  21. MATHIJSSEN H, Bawaskar PH, Shenoy C
    Cardiovascular magnetic resonance phenotyping in cardiac sarcoidosis: simplicity is indeed the ultimate sophistication for primary prevention implantable cardioverter-defibrillator decisions.
    Eur Heart J. 2025 Dec 19:ehaf1027. doi: 10.1093/eurheartj/ehaf1027.
    >> Share

  22. CREA F
    Focus on the many facets of atrial fibrillation: from prediction to treatment.
    Eur Heart J. 2025;46:5101-5105.
    >> Share

  23. KARAKASIS P, Antoniadis AP, Fragakis N
    Atrial remodeling in persistent atrial fibrillation: Energy source or lesion set?
    Eur Heart J. 2025 Dec 12:ehaf914. doi: 10.1093.
    >> Share

  24. MACRAE CA
    Genetic testing in cardiology: insights into 'overlap' from atrial fibrillation.
    Eur Heart J. 2025 Dec 12:ehaf988. doi: 10.1093.
    >> Share

    November 2025
  25. OZKARTAL T, Bergonti M, Conte G
    Trouble shooting for unexpected bradycardia after atrial leadless pacemaker implantation.
    Eur Heart J. 2025 Nov 28:ehaf986. doi: 10.1093.
    >> Share

  26. MYHRE PL, Hoff NJS, Lund LH
    Potential role of repeated Valsalva manoeuvres in atrial fibrillation risk among elite rowers.
    Eur Heart J. 2025 Nov 28:ehaf969. doi: 10.1093.
    >> Share

  27. LA GERCHE A, Spencer LW, Myrstad M, Flannery DM, et al
    Maybe Valsalva, but please consider big hearts in middle-aged athletes as an explanation for atrial fibrillation prevalence.
    Eur Heart J. 2025 Nov 28:ehaf970. doi: 10.1093.
    >> Share

  28. SCHNABEL RB, Rienstra M
    Integrated care: a pathway to successful atrial fibrillation catheter ablation.
    Eur Heart J. 2025 Nov 25:ehaf938. doi: 10.1093.
    >> Share

  29. HAMDANI N, Akin I, El-Battrawy I
    Gene-therapy in inherited channelopathies like short-QT syndrome: a robust direction towards precision medicine.
    Eur Heart J. 2025 Nov 20:ehaf831. doi: 10.1093.
    >> Share

  30. BINDING C, Elmegaard M, Larsen S, Boysen EK, et al
    Temporal trends in the use of oral anticoagulants and clinical outcomes in older, elderly, and very elderly patients with atrial fibrillation: a Danish nationwide study.
    Eur Heart J. 2025 Nov 18:ehaf877. doi: 10.1093.
    >> Share

  31. DUNCKER D, Marijon E, Metra M, Piot O, et al
    Sudden cardiac death in newly diagnosed non-ischaemic or ischaemic cardiomyopathy assessed with a wearable cardioverter-defibrillator: the German nationwide SCD-PROTECT study.
    Eur Heart J. 2025;46:4597-4606.
    >> Share

  32. SHAMLOO AS, Di Biase L, Arya A
    Clinical consensus statement on epicardial ventricular arrhythmia ablation: key messages.
    Eur Heart J. 2025 Nov 11:ehaf741. doi: 10.1093.
    >> Share

  33. NATTEL S
    Left-atrial low-voltage areas and sex: mechanisms and insights into sex-related differences in atrial fibrillation susceptibility.
    Eur Heart J. 2025 Nov 11:ehaf767. doi: 10.1093.
    >> Share

  34. BAYKANER T, Butler J
    Managing atrial fibrillation-mediated cardiomyopathy: the causality-consequence conundrum.
    Eur Heart J. 2025 Nov 11:ehaf764. doi: 10.1093.
    >> Share

  35. MERINO JL, Reiffel JA, Camm AJ
    EHRA practical compendium of antiarrhythmic drugs: 10 key messages on contemporary use.
    Eur Heart J. 2025 Nov 7:ehaf805. doi: 10.1093.
    >> Share

  36. CREA F
    Focus on trials: primary prevention, ischaemic heart disease, atrial fibrillation, and obstructive sleep apnoea.
    Eur Heart J. 2025;46:4347-4350.
    >> Share

  37. SCHUBERT MR, Sinner MF
    Understanding atrial cardiomyopathy: a missing link in the prevention of atrial fibrillation, heart failure, and stroke?
    Eur Heart J. 2025 Nov 6:ehaf832. doi: 10.1093.
    >> Share

  38. ZHOU F, Li J, Lu M
    From myocarditis to arrhythmogenic right ventricular cardiomyopathy: a diagnostic odyssey in a young male with recurrent chest symptoms.
    Eur Heart J. 2025 Nov 6:ehaf864. doi: 10.1093.
    >> Share

    October 2025
  39. LAWS JL, Shabani M, Williams HL, Grauherr DD, et al
    Genetic evaluation of early-onset atrial fibrillation: impact on patient management.
    Eur Heart J. 2025 Oct 30:ehaf829. doi: 10.1093.
    >> Share

  40. LI Q, Lv TT, Zhang P
    Implantable cardioverter-defibrillator for primary prevention in children and adolescents with long QT syndrome: rethinking the boundaries.
    Eur Heart J. 2025 Oct 23:ehaf807. doi: 10.1093.
    >> Share

  41. VAD OB, van Vreeswijk N, Yassin AS, Blaauw Y, et al
    Atrial cardiomyopathy: markers and outcomes.
    Eur Heart J. 2025 Oct 15:ehaf793. doi: 10.1093.
    >> Share

  42. GIAMMARINO L, Odening KE
    Towards a personalized, mechanism-based risk prediction of post-operative atrial fibrillation.
    Eur Heart J. 2025 Oct 14:ehaf731. doi: 10.1093.
    >> Share

  43. REINSTADLER SJ, Schreinlechner M, Bauer A
    Digital screening for atrial fibrillation to prevent stroke: the Austrian Digital Heart Program.
    Eur Heart J. 2025 Oct 3:ehaf714. doi: 10.1093.
    >> Share

    September 2025
  44. NAKASHIMA K, Yamaguchi T, Takahashi Y, Otsubo T, et al
    Sex differences in atrial fibrillation-related atrial remodelling assessed by electroanatomic mapping and biopsy.
    Eur Heart J. 2025 Sep 25:ehaf768. doi: 10.1093.
    >> Share

  45. MATHIJSSEN H, Bawaskar PH, Shenoy C
    Cardiovascular magnetic resonance phenotyping: the new standard for primary prevention implantable cardioverter-defibrillator decision-making in cardiac sarcoidosis.
    Eur Heart J. 2025 Sep 25:ehaf759. doi: 10.1093.
    >> Share

  46. POYHONEN P, Kandolin R, Kupari M
    Cardiovascular magnetic resonance in the assessment of the risk of fatal or life-threatening ventricular arrhythmias in suspected vs diagnosed cardiac sarcoidosis.
    Eur Heart J. 2025 Sep 25:ehaf758. doi: 10.1093.
    >> Share

  47. KELTERS IR, Koop Y, Young ME, Daiber A, et al
    Circadian rhythms in cardiovascular disease.
    Eur Heart J. 2025;46:3532-3545.
    >> Share

  48. JASTRZEBSKI M, Kielbasa G, Cano O, Curila K, et al
    Left bundle branch area pacing vs right ventricular pacing for atrioventricular block: the MELOS RELOADED study.
    Eur Heart J. 2025 Sep 22:ehaf699. doi: 10.1093.
    >> Share

  49. AGUILAR M, Macle L, Ditac G, Benali K, et al
    Atrial fibrillation burden is underestimated by non-invasive monitoring: the CIRCA-DOSE trial.
    Eur Heart J. 2025 Sep 16:ehaf647. doi: 10.1093.
    >> Share

  50. WHINNETT Z, Naraen A, Vijayaraman P, Cleland JGF, et al
    Physiological pacing: mechanisms, clinical indications, and perspectives.
    Eur Heart J. 2025;46:3407-3419.
    >> Share

  51. ZENG Z, Wang X, Pei J, Wang P, et al
    Endothelial plasticity in atrial fibrosis by integrating single-cell sequencing and genetic lineage tracing.
    Eur Heart J. 2025;46:3470-3482.
    >> Share

  52. CHRISTENSEN AH, Pan G, Marvig RL, Rodriguez Gonzalez FG, et al
    Gain-of-function enhancer variant near KCNB1 causes familial ST-depression syndrome.
    Eur Heart J. 2025;46:3486-3497.
    >> Share

  53. GOETTE A
    Not all atrial fibrillations are born equal: the impact of chronobiology.
    Eur Heart J. 2025 Sep 15:ehaf582. doi: 10.1093.
    >> Share

  54. FAKUADE FE, Gronwald J, Brandes P, Doring Y, et al
    Cytosolic calcium handling signature: integration with clinical predictors enhances prediction of post-operative atrial fibrillation.
    Eur Heart J. 2025 Sep 9:ehaf609. doi: 10.1093.
    >> Share

  55. YUAN X, Ju F, Wu H, Zhao Y, et al
    Surgical left atrial appendage occlusion in valvular heart disease without atrial fibrillation: the OPINION trial.
    Eur Heart J. 2025 Sep 1:ehaf674. doi: 10.1093.
    >> Share

    August 2025
  56. NIMANI S, Bains S, Alerni N, Ordog B, et al
    AAV9-mediated KCNH2 suppression-replacement gene therapy in a transgenic rabbit model of type 1 short QT syndrome.
    Eur Heart J. 2025 Aug 30:ehaf660. doi: 10.1093.
    >> Share

  57. LINZ D, Chaldoupi SM
    Hypokalaemia in atrial fibrillation: a red flag for more comprehensive workup?
    Eur Heart J. 2025 Aug 30:ehaf651. doi: 10.1093.
    >> Share

  58. HESSELLUND AK, Kongebro EK, Haugan KJ, Graff C, et al
    Hypokalaemia and atrial fibrillation detected by implanted loop recorders.
    Eur Heart J. 2025 Aug 30:ehaf623. doi: 10.1093.
    >> Share

  59. VERMEER J, Vinck-de Greef T, van den Broek M, de Louw B, et al
    Improving outcomes of atrial fibrillation ablation by integrated personalized lifestyle interventions: a randomized controlled trial.
    Eur Heart J. 2025 Aug 30:ehaf689. doi: 10.1093.
    >> Share

  60. SABA L
    Cerebral signatures of cardiovascular disease: distinct brain lesion patterns in atrial fibrillation and atherosclerosis.
    Eur Heart J. 2025 Aug 29:ehaf551. doi: 10.1093.
    >> Share

  61. SEGAN L, Kistler PM, Nanayakkara S, Taylor A, et al
    Catheter ablation vs rate control in atrial fibrillation with left ventricular systolic dysfunction and fibrosis: the CAMERA-MRI II trial.
    Eur Heart J. 2025 Aug 29:ehaf604. doi: 10.1093.
    >> Share

  62. STEGMANN T, Joundi RA, Srivastava A, Sinnecker T, et al
    Atrial fibrillation and atherosclerosis cause different vascular brain lesions on magnetic resonance imaging.
    Eur Heart J. 2025 Aug 29:ehaf550. doi: 10.1093.
    >> Share

  63. MORA-AYESTARAN N, Ochoa JP, Gomez-Gonzalez C, Navarro-Penalver M, et al
    Arrhythmic genotypes in dilated cardiomyopathy and risk of advanced heart failure.
    Eur Heart J. 2025 Aug 29:ehaf605. doi: 10.1093.
    >> Share

  64. SVENNBERG E, Freedman B, Andrade JG, Anselmino M, et al
    Recent-onset atrial fibrillation: challenges and opportunities.
    Eur Heart J. 2025 Aug 28:ehaf478. doi: 10.1093.
    >> Share

  65. SEGAN L, Kistler PM, Nanayakkara S, Taylor A, et al
    Withdrawal of heart failure therapy after atrial fibrillation rhythm control with ejection fraction normalization: the WITHDRAW-AF trial.
    Eur Heart J. 2025 Aug 12:ehaf563. doi: 10.1093.
    >> Share

  66. CHAO TF, Kuo L
    Intermittent left bundle branch block in a patient with cardiac sarcoidosis.
    Eur Heart J. 2025 Aug 7:ehaf172. doi: 10.1093.
    >> Share

  67. ANDRADE JG, Macle L
    Is atrial remodelling after atrial fibrillation catheter ablation clinically relevant?
    Eur Heart J. 2025 Aug 6:ehaf557. doi: 10.1093.
    >> Share

  68. GUASCH E, Mont L
    Atrial fibrillation in elite rowers: a genetic and endurance sport nexus?
    Eur Heart J. 2025 Aug 1:ehaf410. doi: 10.1093.
    >> Share

  69. TEN CATE H, Ten Berg J
    Fibrin clot lysis predicts anticoagulant-associated bleeding in atrial fibrillation: ready for clinical use?
    Eur Heart J. 2025 Aug 1:ehaf458. doi: 10.1093.
    >> Share

    July 2025
  70. PEDERSEN JJ, Kuhl JT, Elming MB, Pham MHC, et al
    Epicardial adipose tissue and new-onset atrial fibrillation in a Danish cohort.
    Eur Heart J. 2025 Jul 31:ehaf515. doi: 10.1093.
    >> Share

  71. MIYAMOTO K, Kanaoka K, Yodogawa K, Fujimoto Y, et al
    Cryoballoon vs radiofrequency ablation in persistent atrial fibrillation: the CRRF-PeAF trial.
    Eur Heart J. 2025 Jul 24:ehaf451. doi: 10.1093.
    >> Share

  72. NIELSEN-KUDSK JE, Boersma LVA, Camm AJ
    Left atrial appendage closure: a reappraisal of atrial fibrillation guidelines.
    Eur Heart J. 2025 Jul 15:ehaf454. doi: 10.1093.
    >> Share

  73. OBERGASSEL J, Suling A, Borof K, Camm AJ, et al
    Short-term benefit of early rhythm control for atrial fibrillation: the EAST-AFNET 4 trial.
    Eur Heart J. 2025 Jul 10:ehaf397. doi: 10.1093.
    >> Share

  74. SCHWARTZ PJ, Spazzolini C
    Are long QT syndrome patients managed differently in different countries?
    Eur Heart J. 2025 Jul 9:ehaf394. doi: 10.1093.
    >> Share

  75. LUXAN G, Sossalla S
    Endothelial plasticity and fibrosis in atrial fibrillation: reframing the therapeutic landscape for targeted interventions.
    Eur Heart J. 2025 Jul 8:ehaf428. doi: 10.1093.
    >> Share


  76. Correction to: 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): Developed by the task force for the management of atrial fibrillation of the Eur
    Eur Heart J. 2025 Jul 7:ehaf306. doi: 10.1093.
    >> Share


  77. Correction to: Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study.
    Eur Heart J. 2025 Jul 3:ehaf434. doi: 10.1093.
    >> Share

  78. LIPPERT L, Burkard T, Markel F, Debus V, et al
    Long QT syndrome in children and adolescents: risk factors and outcomes in a large German cohort.
    Eur Heart J. 2025 Jul 2:ehaf365. doi: 10.1093.
    >> Share

    June 2025
  79. FLANNERY MD, Canovas R, Janssens K, Mitchell AM, et al
    Atrial fibrillation in former world-class rowers: role of environmental and genetic factors.
    Eur Heart J. 2025 Jun 25:ehaf369. doi: 10.1093.
    >> Share

  80. SPONA DC, Haugan KJ, Graff C, Hojberg S, et al
    Circadian patterns of atrial fibrillation and disease progression assessed by implanted loop recorders.
    Eur Heart J. 2025 Jun 16:ehaf386. doi: 10.1093.
    >> Share

  81. LINDE C, Packer M, Bauersachs J
    Great debate: ablation of atrial fibrillation should be performed in patients with heart failure with reduced ejection fraction.
    Eur Heart J. 2025 Jun 10:ehaf182. doi: 10.1093.
    >> Share

  82. SALEEM-TALIB S, Hoevenaars CPR, Molitor N, van Driel VJ, et al
    Leadless pacing: a comprehensive review.
    Eur Heart J. 2025;46:1979-1990.
    >> Share

    May 2025
  83. PARKER WAE, Nelson TA, Lee J, Judge HM, et al
    Pre-treatment lysis time of plasma-derived fibrin clots and bleeding in patients on oral anticoagulants for atrial fibrillation in the ARISTOTLE trial.
    Eur Heart J. 2025 May 30:ehaf347. doi: 10.1093.
    >> Share

  84. MATHIJSSEN H, Bawaskar PH, Rochlani Y, Georgy I, et al
    Prediction of ventricular arrhythmic outcomes in suspected cardiac sarcoidosis: a comparison of cardiovascular magnetic resonance phenotyping vs. societal recommendations for implantable cardioverter-defibrillator placement.
    Eur Heart J. 2025 May 22:ehaf338. doi: 10.1093.
    >> Share

  85. SHINZATO K, Takahashi Y, Yamaguchi T, Otsubo T, et al
    Atrial amyloidosis identified by biopsy in atrial fibrillation: prevalence and clinical presentation.
    Eur Heart J. 2025 May 20:ehaf332. doi: 10.1093.
    >> Share

  86. WANG J, Verkerk AO, Wilders R, Zhang Y, et al
    SCN10A-short gene therapy to restore conduction and protect against malignant cardiac arrhythmias.
    Eur Heart J. 2025;46:1747-1762.
    >> Share

  87. NOUBIAP JJ, Dewland TA, Montenegro GC, Oo HH, et al
    Illicit stimulants and ventricular arrhythmias: a longitudinal cohort study.
    Eur Heart J. 2025 May 7:ehaf282. doi: 10.1093.
    >> Share

  88. CREA F
    Key topics: sex-related differences in vascular surgery; atrial fibrillation and cognitive performance; and gene therapy of ventricular arrhythmias.
    Eur Heart J. 2025;46:1689-1692.
    >> Share

  89. CLAUSS S, Nahrendorf M, Kaab S
    Leducq-funded programme: immune targets for the treatment of atrial fibrillation.
    Eur Heart J. 2025 May 6:ehaf176. doi: 10.1093.
    >> Share

  90. KALMAN JM, Saad E, Gerstenfeld EP
    Knowledge gaps in the 2024 consensus statement on atrial fibrillation ablation.
    Eur Heart J. 2025 May 6:ehaf175. doi: 10.1093.
    >> Share

    April 2025
  91. LODIN K, Da Silva CO, Wang Gottlieb A, Bulatovic I, et al
    Mitral annular disjunction and mitral valve prolapse: long-term risk of ventricular arrhythmias after surgery.
    Eur Heart J. 2025 Apr 15:ehaf195. doi: 10.1093.
    >> Share

  92. ZHANG D
    Cholinergic control of cardiac electrical conduction and ventricular arrhythmia: endogenous or exogenous?
    Eur Heart J. 2025 Apr 9:ehaf011. doi: 10.1093.
    >> Share

  93. CREA F
    Focus on blood pressure: sex-specific association with atrial fibrillation, role of gliflozins in hypertension, and new therapeutic targets in hypertension and orthostatic hypotension.
    Eur Heart J. 2025;46:1277-1280.
    >> Share

  94. YUAN Y, Martsch P, Chen X, Martinez E, et al
    Atrial cardiomyocyte-restricted cleavage of gasdermin D promotes atrial arrhythmogenesis.
    Eur Heart J. 2025;46:1250-1262.
    >> Share

  95. XIE D, Xiong K, Dong N, Wang G, et al
    An endogenous cholinergic system controls electrical conduction in the heart.
    Eur Heart J. 2025;46:1232-1246.
    >> Share

  96. CREA F
    Learning from epidemiology: atrial fibrillation, peripheral artery disease, and twin pregnancy.
    Eur Heart J. 2025;46:1173-1177.
    >> Share

    March 2025
  97. SIONTIS KC, Friedman PA
    Predicting imminent ventricular arrhythmias from ambulatory ECG signals: far-reaching or too far to reach?
    Eur Heart J. 2025 Mar 30:ehaf008. doi: 10.1093.
    >> Share

  98. FIORINA L, Carbonati T, Narayanan K, Li J, et al
    Near-term prediction of sustained ventricular arrhythmias applying artificial intelligence to single-lead ambulatory electrocardiogram.
    Eur Heart J. 2025 Mar 30:ehaf073. doi: 10.1093.
    >> Share

  99. GALLI M, Patrono C
    Weekly Journal Scan: Uncoupling thrombosis from hemostasis in atrial fibrillation? An AZALEA surfing over troubled water.
    Eur Heart J. 2025 Mar 25:ehaf145. doi: 10.1093.
    >> Share

  100. MAHMOUD B, Cox MGPJ, de Brouwer R, van der Heide MYC, et al
    Epicardial adipose tissue and malignant ventricular arrhythmias in phospholamban p.(Arg14del) variant carriers.
    Eur Heart J. 2025 Mar 11:ehaf118. doi: 10.1093.
    >> Share

  101. CREA F
    Non-traditional risk factors and artificial intelligence in the management of atrial fibrillation.
    Eur Heart J. 2025;46:771-774.
    >> Share

    February 2025
  102. BRUNO RM, Petiot EV
    Sex-specific pathways from vascular ageing to cardiac damage: unfavourable pulse pressure trajectories induce atrial fibrillation in women.
    Eur Heart J. 2025 Feb 24:ehaf039. doi: 10.1093.
    >> Share

  103. GUO J, Zhang Z, Meng X, Jing J, et al
    Atrial fibrillation catheter ablation, brain glymphatic function, and cognitive performance.
    Eur Heart J. 2025 Feb 21:ehaf036. doi: 10.1093.
    >> Share

  104. BUNCH TJ
    Taking out the trash: the role of glymphatic function in cognitive function in patients with atrial fibrillation.
    Eur Heart J. 2025 Feb 21:ehaf040. doi: 10.1093.
    >> Share

  105. LEMOINE M, Rottner L, Kirchhof P
    Asymptomatic atrial fibrillation: the tasks ahead.
    Eur Heart J. 2025 Feb 3:ehae835. doi: 10.1093.
    >> Share

    January 2025
  106. KOTECHA D, Rienstra M, Van Gelder IC
    The '10 commandments' for the 2024 European Society of Cardiology guidelines on atrial fibrillation.
    Eur Heart J. 2025 Jan 29:ehae847. doi: 10.1093.
    >> Share

  107. VERGALLO R, Pedicino D
    Weekly Journal Scan: Is left atrial appendage closure a safe and effective OPTION after ablation for atrial fibrillation?
    Eur Heart J. 2025 Jan 28:ehae922. doi: 10.1093.
    >> Share

  108. GASPERETTI A, Carrick RT, Protonotarios A, Murray B, et al
    Clinical features and outcomes in carriers of pathogenic desmoplakin variants.
    Eur Heart J. 2025;46:362-376.
    >> Share

  109. TZEIS S, Sepehri Shamloo A
    The decalogue of the 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society consensus document on catheter and surgical ablation of atrial fibrillation.
    Eur Heart J. 2025 Jan 17:ehae375. doi: 10.1093.
    >> Share

  110. SHARASHOVA E, Gerdts E, Ball J, Schnabel RB, et al
    Long-term pulse pressure trajectories and risk of incident atrial fibrillation: the Tromso Study.
    Eur Heart J. 2025 Jan 17:ehaf005. doi: 10.1093.
    >> Share

  111. CREA F
    Focus on trials and prevention: suspected angina, atrial fibrillation, COVID, wine consumption, and physical activity.
    Eur Heart J. 2025;46:105-109.
    >> Share

  112. KALMAN JM, Kistler PM, Hindricks G, Sanders P, et al
    Atrial fibrillation ablation timing: where is the sweet spot?
    Eur Heart J. 2025 Jan 3:ehae892. doi: 10.1093.
    >> Share

    December 2024
  113. ZHAO ZG, Chen F, Feng Y
    Left ventriculo-atrial fistula following catheter ablation for Wolff-Parkinson-White syndrome.
    Eur Heart J. 2024 Dec 24:ehae901. doi: 10.1093.
    >> Share

  114. LU Y, Sun Y, Cai L, Yu B, et al
    Non-traditional risk factors for atrial fibrillation: epidemiology, mechanisms, and strategies.
    Eur Heart J. 2024 Dec 24:ehae887. doi: 10.1093.
    >> Share

  115. BORIANI G, Mei DA, Lip GYH
    Artificial intelligence in patients with atrial fibrillation to manage clinical complexity and comorbidities: the ARISTOTELES project.
    Eur Heart J. 2024 Dec 11:ehae792. doi: 10.1093.
    >> Share

  116. RIBEIRO AH, Ribeiro ALP
    AI-ECG and prediction of new atrial fibrillation: when the heart tells the age.
    Eur Heart J. 2024 Dec 9:ehae809. doi: 10.1093.
    >> Share

  117. VAN LOON T, Rijks J, van Koll J, Wolffs J, et al
    Accelerated atrial pacing reduces left-heart filling pressure: a combined clinical-computational study.
    Eur Heart J. 2024;45:4953-4964.
    >> Share

  118. BRUNNER S, Krewitz C, Winter R, von Falkenhausen AS, et al
    Acute alcohol consumption and arrhythmias in young adults: the MunichBREW II study.
    Eur Heart J. 2024;45:4938-4949.
    >> Share

  119. CREA F
    Focus on atrial fibrillation: role of atrioventricular node ablation, prediction by deep learning, and anticoagulation in device-detected arrhythmia.
    Eur Heart J. 2024;45:4873-4877.
    >> Share

  120. LIUZZO G, Patrono C
    Weekly Journal Scan: An EPIC comparison of edoxaban vs. dual antithrombotic therapy in atrial fibrillation and stable coronary artery disease.
    Eur Heart J. 2024 Dec 4:ehae787. doi: 10.1093.
    >> Share

  121. SUN Y, Wang Z, Qian Y
    What's the relationship between secondary mitral regurgitation and secondary tricuspid regurgitation in atrial fibrillation patients and how to treat them?
    Eur Heart J. 2024 Dec 4:ehae815. doi: 10.1093.
    >> Share

    November 2024
  122. CHO S, Eom S, Kim D, Kim TH, et al
    Artificial intelligence-derived electrocardiographic aging and risk of atrial fibrillation: a multi-national study.
    Eur Heart J. 2024 Nov 29:ehae790. doi: 10.1093.
    >> Share

  123. KONERU JN, Ellenbogen KA
    Ablation of persistent atrial fibrillation: lessons learnt from the CAPLA trial.
    Eur Heart J. 2024 Nov 27:ehae832. doi: 10.1093.
    >> Share

  124. MEYER M
    Accelerated pacing as a treatment for heart failure with preserved ejection fraction and atrial fibrillation?
    Eur Heart J. 2024 Nov 26:ehae766. doi: 10.1093.
    >> Share

  125. ORTEGA-MARTORELL S, Olier I, Lip GYH
    A European network to develop virtual twin technology for personalized stroke management in atrial fibrillation: the TARGET consortium.
    Eur Heart J. 2024 Nov 20:ehae673. doi: 10.1093.
    >> Share

  126. LINZ D, Chaldoupi SM
    Stroke risk in device-detected atrial fibrillation is modulated by the continuum of vascular disease burden.
    Eur Heart J. 2024 Nov 19:ehae797. doi: 10.1093.
    >> Share

  127. VERKAIK BJ, Walker RG, Taylor TG, Ekkel MM, et al
    Defibrillation and refractory ventricular fibrillation.
    Eur Heart J. 2024 Nov 18:ehae767. doi: 10.1093.
    >> Share

  128. NEEFS J, Krul SPJ, de Groot JR
    A CHA2DS2-VASc score of 1 is not the same for every patient with atrial fibrillation.
    Eur Heart J. 2024 Nov 11:ehae511. doi: 10.1093.
    >> Share

  129. BORIANI G, Mei DA, Imberti JF
    Personalized clinical management of patients with atrial fibrillation: is a biomarker-based strategy for prediction of sinus rhythm persistence ready for prime time?
    Eur Heart J. 2024 Nov 9:ehae720. doi: 10.1093.
    >> Share

  130. KANY S, Ellinor PT, Khurshid S
    Another piece in the puzzle of atrial fibrillation risk: clinical, genetic, and electrocardiogram-based artificial intelligence.
    Eur Heart J. 2024 Nov 4:ehae691. doi: 10.1093.
    >> Share

    October 2024
  131. LIUZZO G, Patrono C
    Weekly Journal Scan: the rise and OCEANIC fall of asundexian in atrial fibrillation.
    Eur Heart J. 2024 Oct 25:ehae728. doi: 10.1093.
    >> Share

  132. TARANTINO A, Ciconte G, Melgari D, Frosio A, et al
    NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implications.
    Eur Heart J. 2024;45:4336-4348.
    >> Share

  133. KARAKASIS P, Pamporis K, Siontis KC, Theofilis P, et al
    Major clinical outcomes in symptomatic vs. asymptomatic atrial fibrillation: a meta-analysis.
    Eur Heart J. 2024 Oct 21:ehae694. doi: 10.1093.
    >> Share

  134. CREA F
    Innovative approaches to the management of recurrent atrial fibrillation, aortic dilation, and Brugada syndrome.
    Eur Heart J. 2024;45:4245-4248.
    >> Share

  135. CHARTON J, Bouteiller X, Gandjbakhch E, Waintraub X, et al
    Overdrive pacing for ventricular fibrillation storm after myocardial infarction.
    Eur Heart J. 2024 Oct 18:ehae698. doi: 10.1093.
    >> Share

  136. ORAII A, Healey JS, McIntyre WF
    Mineralocorticoid receptor antagonists for atrial fibrillation prevention: effective solution or empty promise?
    Eur Heart J. 2024 Oct 17:ehae687. doi: 10.1093.
    >> Share

  137. SAMPAIO RODRIGUES T, Sanders P, Lim HS
    Utility of mineralocorticoid receptor antagonists in reducing burden of atrial fibrillation.
    Eur Heart J. 2024 Oct 17:ehae686. doi: 10.1093.
    >> Share


  138. Correction to: An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis.
    Eur Heart J. 2024 Oct 15:ehae394. doi: 10.1093.
    >> Share

  139. JOZA J, Burri H, Andrade JG, Linz D, et al
    Atrioventricular node ablation for atrial fibrillation in the era of conduction system pacing.
    Eur Heart J. 2024 Oct 14:ehae656. doi: 10.1093.
    >> Share

  140. GALIUTO L, Patrono C
    Weekly Journal Scan: Risk factors for recurrent ischaemic stroke in patients with atrial fibrillation on oral anticoagulation.
    Eur Heart J. 2024 Oct 3:ehae630. doi: 10.1093.
    >> Share


  141. Correction to: Prognostic value of ventricular arrhythmia in early post-infarction left ventricular dysfunction: the French nationwide WICD-MI study.
    Eur Heart J. 2024 Oct 1:ehae693. doi: 10.1093.
    >> Share

    September 2024
  142. XU Y, Li H, Santosa A, Wettermark B, et al
    Cardiovascular events following coronavirus disease 2019 vaccination in adults: a nationwide Swedish study.
    Eur Heart J. 2024 Sep 30:ehae639. doi: 10.1093.
    >> Share

  143. CREA F
    New Guidelines and a focus on ischaemic heart disease, atrial fibrillation, innovative treatments of channelopathies.
    Eur Heart J. 2024;45:3299-3302.
    >> Share

  144. NATALE A, Mohanty S, Sanders P, Anter E, et al
    Catheter ablation for atrial fibrillation: indications and future perspective.
    Eur Heart J. 2024 Sep 26:ehae618. doi: 10.1093.
    >> Share

  145. ECHIVARD M, Sellal JM, Ziliox C, Marijon E, et al
    Prognostic value of ventricular arrhythmia in early post-infarction left ventricular dysfunction: the French nationwide WICD-MI study.
    Eur Heart J. 2024 Sep 20:ehae575. doi: 10.1093.
    >> Share

  146. GAWALKO M, Middeldorp ME, Saljic A, Penders J, et al
    Diet and risk of atrial fibrillation: a systematic review.
    Eur Heart J. 2024 Sep 17:ehae551. doi: 10.1093.
    >> Share

  147. SCHNABEL RB, Benezet-Mazuecos J, Becher N, McIntyre WF, et al
    Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials.
    Eur Heart J. 2024 Sep 2:ehae596. doi: 10.1093.
    >> Share

  148. HAVERS-BORGERSEN E, Hartwell D, Ekelund C, Butt JH, et al
    Endometriosis and Long-Term Cardiovascular Risk: A Nationwide Danish study.
    Eur Heart J. 2024 Sep 2:ehae563. doi: 10.1093.
    >> Share

  149. LIP GYH, Teppo K, Nielsen PB
    CHA2DS2-VASc or a non-sex score (CHA2DS2-VA) for stroke risk prediction in atrial fibrillation: contemporary insights and clinical implications.
    Eur Heart J. 2024 Sep 1:ehae540. doi: 10.1093.
    >> Share

  150. CHAMPSI A, Mobley AR, Subramanian A, Nirantharakumar K, et al
    Gender and contemporary risk of adverse events in atrial fibrillation.
    Eur Heart J. 2024 Sep 1:ehae539. doi: 10.1093.
    >> Share

  151. JABBOUR G, Nolin-Lapalme A, Tastet O, Corbin D, et al
    Prediction of incident atrial fibrillation using deep learning, clinical models and polygenic scores.
    Eur Heart J. 2024 Sep 1:ehae595. doi: 10.1093.
    >> Share

    August 2024
  152. WILLIAM J, Chieng D, Curtin AG, Sugumar H, et al
    Radiofrequency catheter ablation of persistent atrial fibrillation by pulmonary vein isolation with or without left atrial posterior wall isolation: long-term outcomes of the CAPLA trial.
    Eur Heart J. 2024 Aug 31:ehae580. doi: 10.1093.
    >> Share

  153. FABRITZ L, Al-Taie C, Borof K, Breithardt G, et al
    Biomarker-based prediction of sinus rhythm in atrial fibrillation patients: the EAST-AFNET 4 biomolecule study.
    Eur Heart J. 2024 Aug 31:ehae611. doi: 10.1093.
    >> Share

  154. VAN GELDER IC, Rienstra M, Bunting KV, Casado-Arroyo R, et al
    2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).
    Eur Heart J. 2024 Aug 30:ehae176. doi: 10.1093.
    >> Share

  155. HUANG H, Liu Y, Shuai W, Jiang C, et al
    Atrial tachyarrhythmia prevention by Shensong Yangxin after catheter ablation for persistent atrial fibrillation: the SS-AFRF trial.
    Eur Heart J. 2024 Aug 23:ehae532. doi: 10.1093.
    >> Share

  156. BOVEDA S, Sarkozy A, Duncker D, Merino JL, et al
    European Heart Rhythm Association congress: a constantly reinvented meeting.
    Eur Heart J. 2024;45:2905-2907.
    >> Share

  157. CARRICK RT, Gasperetti A, Protonotarios A, Murray B, et al
    A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers.
    Eur Heart J. 2024;45:2968-2979.
    >> Share

  158. CREA F
    Expanding knowledge in atrial fibrillation, blood pressure treatment, and management of coronary and peripheral artery disease.
    Eur Heart J. 2024;45:2795-2799.
    >> Share

  159. CONTE G, Bergonti M
    Implantable loop recorders in Brugada syndrome: symptoms and arrhythmia characterization.
    Eur Heart J. 2024;45:2895.
    >> Share

  160. DENDRAMIS G
    Implantable loop recorders in patients with Brugada syndrome: the importance of a correct patient stratification.
    Eur Heart J. 2024;45:2894.
    >> Share

  161. BAINS S, Giammarino L, Nimani S, Alerni N, et al
    KCNQ1 suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndrome.
    Eur Heart J. 2024 Aug 8:ehae476. doi: 10.1093.
    >> Share

  162. CREA F
    Spotlight on hot topics: subclinical atrial fibrillation, risk stratification of channelopathies, and cardioprotection.
    Eur Heart J. 2024;45:2579-2583.
    >> Share

  163. TSUJI T, Hasegawa K, Tada H
    Left atrial diverticulum as a rare but possible origin of a sustained atrial tachycardia: a case report.
    Eur Heart J. 2024;45:2679.
    >> Share

    July 2024
  164. KANY S, Jurgens SJ, Ramo JT, Christophersen IE, et al
    Genetic testing in early-onset atrial fibrillation.
    Eur Heart J. 2024 Jul 19:ehae298. doi: 10.1093.
    >> Share

  165. LANDMESSER U, Skurk C, Tzikas A, Falk V, et al
    Left atrial appendage closure for stroke prevention in atrial fibrillation: current status and perspectives.
    Eur Heart J. 2024 Jul 19:ehae398. doi: 10.1093.
    >> Share

  166. ANDREOTTI F, De Caterina R
    Anticoagulation for transient atrial fibrillation post-coronary bypass: high quality evidence needed.
    Eur Heart J. 2024 Jul 16:ehae402. doi: 10.1093.
    >> Share

  167. KAJIHARA Y
    Edoxaban-induced oesophagitis.
    Eur Heart J. 2024;45:2460.
    >> Share

  168. CHOI YJ, Lim J, Bea S, Lee J, et al
    Thromboembolism after coronavirus disease 2019 vaccination in atrial fibrillation/flutter: a self-controlled case series study.
    Eur Heart J. 2024 Jul 12:ehae335. doi: 10.1093.
    >> Share

  169. CONNORS JM
    Thrombotic risks associated with COVID-19 vaccination in atrial fibrillation or atrial flutter: no reason for alarm.
    Eur Heart J. 2024 Jul 12:ehae336. doi: 10.1093.
    >> Share

  170. WILDE AAM, van der Werf C
    Risk scores in congenital long QT syndrome: friend or foe?
    Eur Heart J. 2024 Jul 10:ehae408. doi: 10.1093.
    >> Share

  171. CREA F
    A new classification of iron-deficient heart failure, sex-related differences in the management of atrial fibrillation and mitral regurgitation, and an update on the genetics of Brugada syndrome.
    Eur Heart J. 2024;45:2267-2270.
    >> Share

  172. BEHR ER
    Brugada syndrome: can polygenic risk scores help the clinician?
    Eur Heart J. 2024;45:2333-2335.
    >> Share

  173. SCACCIAVILLANI R
    Percutaneous stellate ganglion block for electrical storm treatment: the new rising STAR?
    Eur Heart J. 2024;45:2263.
    >> Share

  174. SAVASTANO S, Baldi E, Rordorf R
    Percutaneous stellate ganglion block and catheter ablation: not enemies but allies in fighting electrical storm.
    Eur Heart J. 2024;45:2264.
    >> Share

  175. ISHIKAWA T, Masuda T, Hachiya T, Dina C, et al
    Brugada syndrome in Japan and Europe: a genome-wide association study reveals shared genetic architecture and new risk loci.
    Eur Heart J. 2024;45:2320-2332.
    >> Share

  176. AIRAKSINEN KEJ, De Sensi F
    Ten years of direct oral anticoagulants: lessons learned and challenges ahead.
    Eur Heart J. 2024;45:2178-2180.
    >> Share

  177. MURARU D, Badano LP
    Impact of new-onset atrial fibrillation on the incidence of tricuspid regurgitation: a call to attention.
    Eur Heart J. 2024 Jul 8:ehae382. doi: 10.1093.
    >> Share

  178. LV L
    What influences the bleeding risk of long-term anticoagulation after catheter ablation in patients with atrial fibrillation at high risk of thromboembolism?
    Eur Heart J. 2024 Jul 2:ehae388. doi: 10.1093.
    >> Share

  179. KANAOKA K, Iwanaga Y
    Oral anticoagulant use after catheter ablation for atrial fibrillation based on thrombo-embolic risk: future studies will be needed for bleeding high-risk group.
    Eur Heart J. 2024 Jul 2:ehae389. doi: 10.1093.
    >> Share

  180. BECHER N, Metzner A, Toennis T, Kirchhof P, et al
    Atrial fibrillation burden: a new outcome predictor and therapeutic target.
    Eur Heart J. 2024 Jul 2:ehae373. doi: 10.1093.
    >> Share

  181. NASER JA, Castrichini M, Ibrahim HH, Scott CG, et al
    Secondary tricuspid regurgitation: incidence, types, and outcomes in atrial fibrillation vs. sinus rhythm.
    Eur Heart J. 2024 Jul 2:ehae346. doi: 10.1093.
    >> Share

    June 2024
  182. CREA F
    A focus on three hot topics: atrial fibrillation, obesity, and climate change.
    Eur Heart J. 2024;45:2105-2108.
    >> Share

  183. SANDERS P, Svennberg E, Diederichsen SZ, Crijns HJGM, et al
    Great debate: device-detected subclinical atrial fibrillation should be treated like clinical atrial fibrillation.
    Eur Heart J. 2024 Jun 27:ehae365. doi: 10.1093.
    >> Share

  184. SAMUEL M, Rienstra M, Van Gelder IC
    Ablation of persistent atrial fibrillation: never say never again.
    Eur Heart J. 2024 Jun 18:ehae374. doi: 10.1093.
    >> Share

  185. KHAIRY P
    A non-invasive gateway to identifying potential substrates for macro-reentrant ventricular tachycardia in tetralogy of Fallot.
    Eur Heart J. 2024;45:2095-2097.
    >> Share

  186. KIMURA Y, Wallet J, Bouyer B, Jongbloed MRM, et al
    Three-dimensional cardiac magnetic resonance allows the identification of slow-conducting anatomical isthmuses in tetralogy of Fallot.
    Eur Heart J. 2024;45:2079-2094.
    >> Share

  187. STEINBERG BA
    Atrial fibrillation and long-term cardiovascular outcomes: bringing the whole picture into focus.
    Eur Heart J. 2024 Jun 7:ehae347. doi: 10.1093.
    >> Share

  188. FARMAKIS D, Filippatos G
    Cancer begets atrial fibrillation ... and vice versa?
    Eur Heart J. 2024 Jun 7:ehae301. doi: 10.1093.
    >> Share

  189. JOHNSON LS, Jiang Y, Luu J, Van Gelder IC, et al
    Emergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry.
    Eur Heart J. 2024 Jun 4:ehae319. doi: 10.1093.
    >> Share

    May 2024
  190. WANG J, Chen X, Zhao S
    Detect and define ventricular arrhythmia substrates in hypertrophic cardiomyopathy.
    Eur Heart J. 2024 May 31:ehae312. doi: 10.1093.
    >> Share

  191. VAN DE KAR MRD, van Brakel TJ, Van't Veer M, van Steenbergen GJ, et al
    Anticoagulation for post-operative atrial fibrillation after isolated coronary artery bypass grafting: a meta-analysis.
    Eur Heart J. 2024 May 29:ehae267. doi: 10.1093.
    >> Share

  192. NAGAE H, Kayawake H, Taniguchi T
    Chest tube-related complete atrioventricular block.
    Eur Heart J. 2024 May 28:ehae315. doi: 10.1093.
    >> Share

  193. BRIEGER D, Freedman B
    Taking the sex out of atrial fibrillation.
    Eur Heart J. 2024 May 24:ehae256. doi: 10.1093.
    >> Share

  194. CHAUHAN A, Banerjee A
    Atrial fibrillation and flutter: reiterating the need to 'Go hard, Go early'.
    Eur Heart J. 2024 May 23:ehae029. doi: 10.1093.
    >> Share

  195. CRIJNS HJGM, Lambiase PD, Sanders P
    The year in cardiovascular medicine 2023: the top 10 papers in arrhythmias.
    Eur Heart J. 2024;45:1730-1732.
    >> Share

  196. CROWLEY R, Chieng D, Sugumar H, Ling LH, et al
    Catheter ablation for persistent atrial fibrillation: patterns of recurrence and impact on quality of life and health care utilisation.
    Eur Heart J. 2024 May 17:ehae291. doi: 10.1093.
    >> Share

  197. DUSI V, Dagradi F, Spazzolini C, Crotti L, et al
    Long QT syndrome: importance of reassessing arrhythmic risk after treatment initiation.
    Eur Heart J. 2024 May 16:ehae289. doi: 10.1093.
    >> Share

  198. SABBAG A, Aabel EW, Castrini AI, Siontis KC, et al
    Mitral valve prolapse: arrhythmic risk during pregnancy and postpartum.
    Eur Heart J. 2024 May 14:ehae224. doi: 10.1093.
    >> Share

  199. ZEPPENFELD K, de Riva M
    Arrhythmic risk in young women with mitral valve prolapse: keep your eyes open but don't jump at every shadow.
    Eur Heart J. 2024 May 14:ehae246. doi: 10.1093.
    >> Share

  200. VANDERSICKEL N, Hendrickx S, Van den Abeele R, Verstraeten B, et al
    Impact of topology on the number of loops during macro-re-entrant atrial tachycardia.
    Eur Heart J. 2024;45:1586-1588.
    >> Share

  201. TAN Y, Tao Y, Wang Z
    Isolated right-sided pericardial effusion following hybrid ablation for long-standing atrial fibrillation.
    Eur Heart J. 2024 May 4:ehae210. doi: 10.1093.
    >> Share

    April 2024
  202. NGO LTH, Peng Y, Denman R, Yang I, et al
    Long-term outcomes after hospitalization for atrial fibrillation or flutter.
    Eur Heart J. 2024 Apr 28:ehae204. doi: 10.1093.
    >> Share

  203. LI YP, Chen JY
    Rapid onset of takotsubo cardiomyopathy induced by left bundle branch area pacing.
    Eur Heart J. 2024;45:1487.
    >> Share


  204. Correction to: XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation.
    Eur Heart J. 2024 Apr 17:ehae227. doi: 10.1093.
    >> Share

  205. CHEN Q, van Rein N, van der Hulle T, Heemelaar JC, et al
    Coexisting atrial fibrillation and cancer: time trends and associations with mortality in a nationwide Dutch study.
    Eur Heart J. 2024 Apr 15:ehae222. doi: 10.1093.
    >> Share

  206. TEPPO K, Airaksinen KEJ, Jaakkola J, Halminen O, et al
    Ischaemic stroke in women with atrial fibrillation: temporal trends and clinical implications.
    Eur Heart J. 2024 Apr 12:ehae198. doi: 10.1093.
    >> Share

  207. PALUDAN-MULLER C, Vad OB, Stampe NK, Diederichsen SZ, et al
    Atrial fibrillation: age at diagnosis, incident cardiovascular events, and mortality.
    Eur Heart J. 2024 Apr 9:ehae216. doi: 10.1093.
    >> Share

  208. LIP GYH, Nikorowitsch J, Sehner S, Becher N, et al
    Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial.
    Eur Heart J. 2024 Apr 9:ehae225. doi: 10.1093.
    >> Share

  209. CREA F
    The complex interaction between cancer, ischaemic heart disease, and heart failure, and a focus on arrhythmias including risk stratification in Brugada syndrome and leadless pacing.
    Eur Heart J. 2024;45:1183-1187.
    >> Share

  210. GAITA F, Cerrato N, Giustetto C
    Can an implantable loop recorder improve risk stratification and appropriate management in Brugada syndrome?
    Eur Heart J. 2024;45:1266-1268.
    >> Share

  211. BERGONTI M, Sacher F, Arbelo E, Crotti L, et al
    Implantable loop recorders in patients with Brugada syndrome: the BruLoop study.
    Eur Heart J. 2024;45:1255-1265.
    >> Share

  212. EL-CHAMI MF, Garweg C, Clementy N, Al-Samadi F, et al
    Leadless pacemakers at 5-year follow-up: the Micra transcatheter pacing system post-approval registry.
    Eur Heart J. 2024;45:1241-1251.
    >> Share

  213. LIUZZO G, Pedicino D
    Weekly journal scan: the KCa2 potassium channel as a promising target for the pharmacologic cardioversion of atrial fibrillation.
    Eur Heart J. 2024 Apr 1:ehae138. doi: 10.1093.
    >> Share

    March 2024
  214. CREA F
    Challenges in arrhythmias: anticoagulation in asymptomatic atrial fibrillation, stellate ganglion block in electrical storm, and ECG for prediction of sudden death.
    Eur Heart J. 2024;45:739-743.
    >> Share

  215. ZURIAGA MA, Pascual-Figal D, Fuster JJ
    Clonal haematopoiesis and cardiac arrythmias: rhythm-altering mutations.
    Eur Heart J. 2024;45:806-808.
    >> Share

  216. SAVASTANO S, Baldi E, Compagnoni S, Rordorf R, et al
    Electrical storm treatment by percutaneous stellate ganglion block: the STAR study.
    Eur Heart J. 2024;45:823-833.
    >> Share

  217. FIALHO GL
    Epilepsy and the heart: can 'brain arrhythmia' lead to cardiac arrhythmias? Back to the basics.
    Eur Heart J. 2024;45:853-854.
    >> Share

  218. PHAM HN, Holmstrom L, Chugh H, Uy-Evanado A, et al
    Dynamic electrocardiogram changes are a novel risk marker for sudden cardiac death.
    Eur Heart J. 2024;45:809-819.
    >> Share

  219. SCHUERMANS A, Vlasschaert C, Nauffal V, Cho SMJ, et al
    Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias.
    Eur Heart J. 2024;45:791-805.
    >> Share

  220. SUN Y, Zhou Y, Yu B, Zhang K, et al
    Frailty, genetic predisposition, and incident atrial fibrillation.
    Eur Heart J. 2024 Mar 5:ehae130. doi: 10.1093.
    >> Share

  221. SUDO K, Nakamura K, Sato A
    Usefulness of endomyocardial biopsy using three-dimensional delivery system for the diagnosis of cardiac amyloidosis with complete atrioventricular block after transcatheter aortic valve implantation.
    Eur Heart J. 2024 Mar 5:ehae137. doi: 10.1093.
    >> Share

  222. MURARU D, Badano LP, Hahn RT, Lang RM, et al
    Atrial secondary tricuspid regurgitation: pathophysiology, definition, diagnosis, and treatment.
    Eur Heart J. 2024 Mar 5:ehae088. doi: 10.1093.
    >> Share

    February 2024
  223. SVENNBERG E, Diederichsen SZ
    Anticoagulation in device-detected atrial fibrillation: a long journey to find the sweet spot.
    Eur Heart J. 2024 Feb 21:ehae044. doi: 10.1093.
    >> Share

  224. CREA F
    Anticoagulation in atrial fibrillation and implantable cardioverter defibrillator implantation in arrhythmogenic right ventricular cardiomyopathy: need for improving patient selection.
    Eur Heart J. 2024;45:491-494.
    >> Share

  225. MALIK V, Shivkumar K
    Stellate ganglion blockade for the management of ventricular arrhythmia storm.
    Eur Heart J. 2024 Feb 15:ehae083. doi: 10.1093.
    >> Share

  226. HOLT A, Nouhravesh N, Strange JE, Kinnberg Nielsen S, et al
    Cannabis for chronic pain: cardiovascular safety in a nationwide Danish study.
    Eur Heart J. 2024;45:475-484.
    >> Share

  227. ZURKAN D, Pitt B, Edelmann F
    Mineralocorticoid receptor antagonists for the prevention of atrial fibrillation in patients with and without heart failure: one more beneficial effect?
    Eur Heart J. 2024 Feb 6:ehae040. doi: 10.1093.
    >> Share

  228. LIUZZO G, Patrono C
    Edoxaban for atrial high-rate episodes: more harm than good?
    Eur Heart J. 2024;45:330-331.
    >> Share

    January 2024
  229. ELLIOTT PM
    Transatlantic differences in the use of implantable cardioverter defibrillators in arrhythmogenic right ventricular cardiomyopathy.
    Eur Heart J. 2024 Jan 30:ehae022. doi: 10.1093.
    >> Share

  230. YOUNES H, Rao S, Marrouche N
    Deciphering connections: how is cryoablation interlinking with disease progression in atrial fibrillation ablation?
    Eur Heart J. 2024 Jan 24:ehad872. doi: 10.1093.
    >> Share

  231. BRIENESSE S, Passman R, Freedman B
    Interruption of oral anticoagulants after atrial fibrillation catheter ablation: the importance of risk stratification.
    Eur Heart J. 2024 Jan 23:ehad874. doi: 10.1093.
    >> Share

  232. DEHARO P, Obadia JF, Guerin P, Cuisset T, et al
    Mitral transcatheter edge to edge repair versus isolated mitral surgery for severe mitral regurgitation: A French nationwide study.
    Eur Heart J. 2024 Jan 19:ehae046. doi: 10.1093.
    >> Share

  233. VERGALLO R, Galiuto L
    Targeting inflammation with colchicine does not prevent atrial fibrillation after major non-cardiac thoracic surgery.
    Eur Heart J. 2024 Jan 18:ehae006. doi: 10.1093.
    >> Share

  234. AHN HJ, An HY, Ryu G, Lim J, et al
    Clonal haematopoiesis of indeterminate potential and atrial fibrillation: an east Asian cohort study.
    Eur Heart J. 2024 Jan 17:ehad869. doi: 10.1093.
    >> Share

  235. SAMARAS A, Papazoglou AS, Balomenakis C, Bekiaridou A, et al
    Residual leaks following percutaneous left atrial appendage occlusion and outcomes: a meta-analysis.
    Eur Heart J. 2024;45:214-229.
    >> Share

  236. ORAII A, Healey JS, Kowalik K, Pandey AK, et al
    Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis of clinical trials.
    Eur Heart J. 2024 Jan 9:ehad811. doi: 10.1093.
    >> Share

  237. CARRICK RT, De Marco C, Gasperetti A, Bosman LP, et al
    Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe.
    Eur Heart J. 2024 Jan 9:ehad799. doi: 10.1093.
    >> Share

  238. LIUZZO G, Patrono C
    Balancing the benefits and risks of anticoagulation in patients with subclinical atrial fibrillation.
    Eur Heart J. 2024 Jan 8:ehad859. doi: 10.1093.
    >> Share

  239. CREA F
    The key role of thrombosis: focus on acute coronary syndrome, venous thrombo-embolism, and atrial fibrillation.
    Eur Heart J. 2024;45:1-4.
    >> Share

  240. PIESZKO K, Hiczkiewicz J, Lojewska K, Uzieblo-Zyczkowska B, et al
    Artificial intelligence in detecting left atrial appendage thrombus by transthoracic echocardiography and clinical features: the Left Atrial Thrombus on Transoesophageal Echocardiography (LATTEE) registry.
    Eur Heart J. 2024;45:32-41.
    >> Share

    December 2023
  241. PROVIDENCIA R, Kukendra-Rajah K, Barra S
    Amiodarone for atrial fibrillation: a dead man walking?
    Eur Heart J. 2023 Dec 29:ehad825. doi: 10.1093.
    >> Share

  242. KRAMARENKO D, Walsh R
    Emery-Dreifuss muscular dystrophy: a closer look at cardiac complications.
    Eur Heart J. 2023;44:5074-5076.
    >> Share

  243. KANAOKA K, Nishida T, Iwanaga Y, Nakai M, et al
    Oral anticoagulation after atrial fibrillation catheter ablation: benefits and risks.
    Eur Heart J. 2023 Dec 20:ehad798. doi: 10.1093.
    >> Share

  244. HATALA R, Hlivak P
    Atrial fibrillation in chronic coronary syndromes: a neglected challenge.
    Eur Heart J. 2023 Dec 17:ehad781. doi: 10.1093.
    >> Share

    November 2023
  245. SPOSATO LA, Lip GYH, Haeusler KG
    Atrial fibrillation first detected after stroke: is timing and detection intensity relevant for stroke risk?
    Eur Heart J. 2023 Nov 28:ehad744. doi: 10.1093.
    >> Share

  246. ANJUM M, Ariansen I, Hjellvik V, Selmer R, et al
    Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study.
    Eur Heart J. 2023 Nov 23:ehad659. doi: 10.1093.
    >> Share

  247. MARCHLINSKI FE, Oraii A, Muser D
    Anticoagulation for atrial fibrillation in patients with intermediate stroke risk: is the grey zone becoming less grey?
    Eur Heart J. 2023 Nov 23:ehad751. doi: 10.1093.
    >> Share

  248. BECHER N, Toennis T, Bertaglia E, Blomstrom-Lundqvist C, et al
    Anticoagulation with edoxaban in patients with long Atrial High-Rate Episodes >/=24 hours.
    Eur Heart J. 2023 Nov 12:ehad771. doi: 10.1093.
    >> Share

  249. TSABAN G, Ostrovsky D, Alnsasra H, Burrack N, et al
    Amiodarone and pulmonary toxicity in atrial fibrillation: a nationwide Israeli study.
    Eur Heart J. 2023 Nov 6:ehad726. doi: 10.1093.
    >> Share

  250. DEMIDOVA MM, Holmqvist F, Erlinge D, Platonov PG, et al
    Ventricular arrhythmias during ST-segment elevation myocardial infarction and arrhythmic complications during recurrent ischaemic events.
    Eur Heart J. 2023 Nov 3:ehad740. doi: 10.1093.
    >> Share

  251. INCIARDI RM, Solomon SD
    Beyond the rhythm: atrial fibrillation, diastolic dysfunction, and heart failure.
    Eur Heart J. 2023 Nov 3:ehad747. doi: 10.1093.
    >> Share

    October 2023
  252. ELLIOTT AD, Benjamin EJ, Middeldorp ME
    Prevention of atrial fibrillation: a call to action.
    Eur Heart J. 2023 Oct 31:ehad738. doi: 10.1093.
    >> Share

  253. TILZ RR, Heeger CH
    Be aware and hit hard and early: oesophageal lesions after atrial fibrillation ablation.
    Eur Heart J. 2023 Oct 26:ehad692. doi: 10.1093.
    >> Share

  254. SCANAVACCA M, Pisani C, Rivarola EWR
    Early identification of oesophageal lesions after atrial fibrillation ablation to prevent atrio-oesophageal fistula.
    Eur Heart J. 2023 Oct 26:ehad689. doi: 10.1093.
    >> Share

  255. CREA F
    Innovative trials in heart failure, dyslipidaemias, and sinus node dysfunction.
    Eur Heart J. 2023;44:4203-4207.
    >> Share

  256. PEDICINO D, Volpe M
    Atrial fibrillation ablation improves outcomes in patients with end-stage heart failure: is it all gold the glitter in the CASTLE?
    Eur Heart J. 2023 Oct 17:ehad675. doi: 10.1093.
    >> Share

  257. MARX N, Federici M, Schutt K, Muller-Wieland D, et al
    2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes.
    Eur Heart J. 2023;44:4043-4140.
    >> Share

  258. APOSTOLOS A, Aggeli C, Toutouzas K
    Nickel hypersensitivity as the cause of atrial fibrillation after patent foramen ovale closure: fact or myth?
    Eur Heart J. 2023 Oct 4:ehad643. doi: 10.1093.
    >> Share

  259. PAPIOL E, Pastor P, Pueo E
    Skin lesions, weight loss, and ventricular tachycardia: connecting the dots to diagnose multisystemic sarcoidosis.
    Eur Heart J. 2023;44:3705.
    >> Share

    September 2023
  260. LI E, Yan C, Yang X
    Long QT syndrome induced by cervical spondylosis.
    Eur Heart J. 2023 Sep 22:ehad608. doi: 10.1093.
    >> Share

  261. CREA F
    Challenges and opportunities in prognostication: focus on ischaemic heart disease and atrial fibrillation.
    Eur Heart J. 2023;44:3391-3394.
    >> Share

  262. TANAKA Y, Kuroki K, Kaga S
    Life-threatening left atrioesophageal fistula complicated with catheter ablation for atrial fibrillation in a patient with aortic stent graft.
    Eur Heart J. 2023 Sep 19:ehad609. doi: 10.1093.
    >> Share

  263. WANG N, Yu Y, Sun Y, Zhang H, et al
    Acquired risk factors and incident atrial fibrillation according to age and genetic predisposition.
    Eur Heart J. 2023 Sep 19:ehad615. doi: 10.1093.
    >> Share

  264. CREA F
    Focus on atrial fibrillation in specific clinical settings and on calmodulinopathy.
    Eur Heart J. 2023;44:3299-3302.
    >> Share

  265. WANG J, Huang P, Yu Q, Lu J, et al
    Epilepsy and long-term risk of arrhythmias.
    Eur Heart J. 2023;44:3374-3382.
    >> Share

  266. BARSHESHET A, Goldenberg I
    Advancing personalized medicine: the power of collaborative registries of patients with inherited cardiac arrhythmia syndromes.
    Eur Heart J. 2023;44:3371-3373.
    >> Share

  267. CROTTI L, Spazzolini C, Nyegaard M, Overgaard MT, et al
    Clinical presentation of calmodulin mutations: the International Calmodulinopathy Registry.
    Eur Heart J. 2023;44:3357-3370.
    >> Share

  268. MOHANTY S, La Fazia VM, Natale A
    The Antwerp score: is this the 'new hope on the horizon'?
    Eur Heart J. 2023;44:3336-3338.
    >> Share

  269. GONG X, Liu JX, Huang XB
    Surgical removal of acoustic neuroma eliminates sick sinus syndrome.
    Eur Heart J. 2023;44:3388.
    >> Share

  270. COURT-KOWALSKI S, McArthur A, Hayres K
    Pulsus paradoxus, electrical alternans, and pulsus alternans in progressive cardiac tamponade.
    Eur Heart J. 2023;44:3297.
    >> Share

  271. MIDDELDORP ME, Sandhu RK
    The stroke enigma: decoding the sex risk factor in atrial fibrillation.
    Eur Heart J. 2023 Sep 6:ehad531. doi: 10.1093.
    >> Share

    August 2023
  272. ESSAYAGH B, Sabbag A, El-Am E, Cavalcante JL, et al
    Arrhythmic mitral valve prolapse and mitral annular disjunction: pathophysiology, risk stratification, and management.
    Eur Heart J. 2023 Aug 10:ehad491. doi: 10.1093.
    >> Share

    April 2023
  273. LEE J, Kim JS, Shim CY
    MitraClip single-leaflet detachment and consequent migration in atrial functional mitral regurgitation.
    Eur Heart J. 2023 Apr 26:ehad249. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016